Competitive Intelligence Leader

The Opportunity

• Strategic Thought Leadership & Competitive Intelligence: Act as a strategic thought partner, providing high-quality insights and recommendations to guide decision-making at the Disease Area (DA), Therapeutic Area (TA), and enterprise levels.
• Analyze and synthesize data from multiple sources (including primary/secondary research, real-world evidence, and AI-driven analytics) to anticipate market evolution, competitor moves, and emerging trends that impact Roche's strategy and competitiveness.
• Competitive Pipeline Development: Shape competitive strategies by informing competitive positioning, TPP creation, and launch plans (value proposition, differentiation, messaging), while leading the assessment of standard-of-care evolution by synthesizing insights at pre-clinical and clinical stages, including emerging trends and modalities.
• Cross-Functional Collaboration & Influence: Partner with key internal stakeholders (GPS, R&D, Product Development, Medical Affairs, Business Development, and commercial teams) to ensure insights are embedded in strategic planning, while fostering collaboration across the lifecycle, functions, and geographies to maximize impact.
• Project, Stakeholder & Vendor Management: Lead and execute strategic initiatives with clear objectives, ensuring timely, high-quality, and impactful deliverables. Manage relationships with external agencies and internal partners, ensuring complete alignment with business priorities and objectives.
• Innovation & AI-Enabled Insights: Champion the adoption of advanced analytics, AI-driven intelligence, and new methodologies to enhance insight generation, and pioneer new ways of working that improve efficiency and decision-making agility across the enterprise.
• External Opportunity & Risk Assessment: Evaluate and provide intelligence on competitor strategies, industry trends, and external business opportunities, collaborating directly with business development and partnering teams to assess investment decisions and potential threats.
• Competitive Readiness & Commercial Execution: Enhance Roche's commercial and launch strategies by ensuring competitive readiness across pre-launch and marketed products, while partnering with affiliate networks to embed a competitive mindset across the organization and maximize portfolio value.

Who You Are

• Education & Language: You hold a Bachelor's Degree in life sciences or a related discipline, though an MD, PharmD, MBA, or PhD in life sciences, technical, or analytical disciplines is preferred. You are also fully proficient in both written and verbal English.
• Professional Experience: You bring 7+ years of experience in pharmaceuticals, biotechnology, or related management consulting, with a strong track record in insights and/or strategy roles, including experience supporting research & development and/or product launch strategies (preferred).
• Strategic & Analytical Capability: You possess a proven ability to develop and connect strategies to impactful decision-making, with exceptional skills in analyzing market dynamics and emerging trends (e.g., standards of care, new modalities, technologies, platforms) to drive strategic implications.
• Advanced Skills: You have exceptional skills in synthesizing insights from diverse sources (primary/secondary CI, congress coverage) into clear, data-driven strategic recommendations, alongside strong storytelling, communication, and interpersonal skills to translate complex data and influence senior leaders without authority.
• You have a demonstrated ability to leverage new technologies to enhance insight generation and monitor competitor strategies to anticipate external threats and opportunities.
• Leadership & Adaptability: You display an exceptional ability to lead high-performing teams and influence cross-functional stakeholders in a matrixed, multicultural environment. You thrive in a fast-paced, dynamic atmosphere, managing ambiguity while driving strategic planning, resource prioritization, and business impact, and you are available to travel up to 25% of the time.